Vaxcyte, Inc.

PCVX

$56.21

Name : Vaxcyte, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $8,364,344,832.00

EPSttm : -7.63

Vaxcyte, Inc.

$56.21

1.21%

$0.69

PCVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.1

Margin Of Safety %

Put/Call OI Ratio

2.32

EPS Next Q Diff

-0.08

EPS Last/This Y

-2.57

EPS This/Next Y

0.98

Price

56.24

Target Price

109

Analyst Recom

1.2

Performance Q

-0.55

Upside

-580.1%

Beta

1.23

Ticker: PCVX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	PCVX	59.81	2.35	0.11	97094
2026-08-31	PCVX	60.76	2.35	1.18	97062
2026-09-01	PCVX	60.81	2.3512040295315	1.2466337522442	97138
2026-09-02	PCVX	61.58	2.24	0.11	106720
2026-09-03	PCVX	61.19	2.16	1.79	114391
2026-09-04	PCVX	61.13	2.16	1.22	114579
2026-09-08	PCVX	60.36	2.15	6.80	114902
2026-09-09	PCVX	59.51	2.29	0.02	118973
2026-09-10	PCVX	58.86	2.28	7.21	119241
2026-09-11	PCVX	59.46	2.28	0.84	119329
2026-09-14	PCVX	59.54	2.27	1.11	119541
2026-09-15	PCVX	59.22	2.27	0.48	119588
2026-09-16	PCVX	58.8	2.27	0.14	119619
2026-09-17	PCVX	60.4	2.27	0.95	119605
2026-09-18	PCVX	58.13	2.27	9.92	119614
2026-09-21	PCVX	58.92	2.30	5.55	117592
2026-09-22	PCVX	59.03	2.32	0.40	118847
2026-09-23	PCVX	56.5	2.30	10.73	119283
2026-09-24	PCVX	56.89	2.32	11.06	119823
2026-09-25	PCVX	56.24	2.32	5.53	119860
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	PCVX	60.04	-37.1	-	-8.20
2026-08-31	PCVX	60.70	-37.1	-	-8.20
2026-09-01	PCVX	60.81	-37.1	-	-8.20
2026-09-02	PCVX	61.60	-37.1	-	-8.20
2026-09-03	PCVX	61.23	-37.1	-	-8.20
2026-09-04	PCVX	61.15	-37.1	-	-8.20
2026-09-08	PCVX	60.36	-37.1	-	-8.20
2026-09-09	PCVX	59.48	-37.1	-	-8.20
2026-09-10	PCVX	58.89	-37.1	-	-8.20
2026-09-11	PCVX	59.48	-37.1	-	-8.20
2026-09-14	PCVX	59.58	-37.1	-	-8.20
2026-09-15	PCVX	59.22	-37.1	-	-8.20
2026-09-16	PCVX	59.22	-37.1	-	-8.20
2026-09-17	PCVX	60.38	-37.1	-	-8.20
2026-09-18	PCVX	58.14	-37.1	-	-8.20
2026-09-21	PCVX	58.88	-37.1	-	-8.20
2026-09-22	PCVX	59.06	-37.1	-	-8.20
2026-09-23	PCVX	56.50	-37.1	-	-8.20
2026-09-24	PCVX	56.90	-37.1	-	-8.20
2026-09-25	PCVX	56.24	-37.1	-	-8.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	PCVX	-3.91	2.31	10.18
2026-08-31	PCVX	-3.91	1.37	10.18
2026-09-01	PCVX	-3.91	1.37	10.18
2026-09-02	PCVX	-3.91	1.37	10.18
2026-09-03	PCVX	-4.00	1.37	10.18
2026-09-04	PCVX	-4.00	1.37	10.18
2026-09-08	PCVX	-4.00	1.62	10.19
2026-09-09	PCVX	-3.88	1.62	10.19
2026-09-10	PCVX	-3.95	1.62	10.19
2026-09-11	PCVX	-4.06	1.62	10.33
2026-09-14	PCVX	-3.80	1.64	10.33
2026-09-15	PCVX	-3.80	1.64	10.33
2026-09-16	PCVX	-3.84	1.64	10.33
2026-09-17	PCVX	-3.84	1.64	10.33
2026-09-18	PCVX	-3.84	1.64	10.33
2026-09-21	PCVX	-3.79	1.64	10.33
2026-09-23	PCVX	-3.79	1.64	10.33
2026-09-24	PCVX	-3.79	1.64	10.33
2026-09-25	PCVX	-3.79	1.64	11.10
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.97

Avg. EPS Est. Current Quarter

-2.14

Avg. EPS Est. Next Quarter

-2.05

Insider Transactions

-3.79

Institutional Transactions

1.64

Beta

1.23

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.5

Max Drawdown 5-Year %

-76.2

Target Price

109

P/E

Forward P/E

PEG

P/S

P/B

2.95

P/Free Cash Flow

EPS

-7.71

Average EPS Est. Cur. Y

-8.2

EPS Next Y. (Est.)

-7.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.72

Return on Equity vs Sector %

-64.9

Return on Equity vs Industry %

-45.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ PCVX Healthcare

$56.21

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

23/25

Volume

9/15

Valuation

9/20

TP/AR

2/10

Options

0/10

RSI

38.8

Range 1M

17.6%

Sup Dist

1.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

8/30

Estimates

0/20

Inst/Vol

4/15

Options

0/10

EPS Yr

-45.8%

EPS NY

20.6%

52W%

74.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +93.9% upside

Quality

2/30

Valuation

15/30

Growth

6/25

Stability

9/10

LT Trend

0/5

Upside

+93.9%

Quality

PCVX — P/E HistoricalBiotechnology

Vaxcyte, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 507

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

PCVX

Latest News

—

Caricamento notizie per PCVX…

stock quote shares PCVX – Vaxcyte Inc. Stock Price stock today

news today PCVX – Vaxcyte Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PCVX – Vaxcyte Inc. yahoo finance google finance

stock history PCVX – Vaxcyte Inc. invest stock market

stock prices PCVX premarket after hours

ticker PCVX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PCVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y